UNITED NATURAL PRODUCT ALLIANCE

  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • UNPA Events & Training >
      • 2021 Training Schedule
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact
  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • UNPA Events & Training >
      • 2021 Training Schedule
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact

member memos

UNPA / FDA's Gottlieb sheds light on agency's go-forward thinking on CBD

3/19/2019

 
Dear Colleagues,

At a Q&A session this afternoon at the Brookings Institute in Washington, outgoing FDA Commissioner Scott Gottlieb, M.D., relayed some important information about the agency’s thinking on cannabidiol (CBD). He also said that he will be leaving the agency on April 5 after providing congressional testimony on the budget, April 3.

On CBD, Gottlieb stated:

  • He did not think the agency’s work would be done before he left, or even before his successor leaves!
  • He indicated that it takes 2-3 years for an “average” rule to be finalized and suggested it would be much longer for CBD, since it would be a “highly novel rulemaking to do a complex rule like this.”
  • He will announce within the week a working group on CBD. It will be led by Lowell Schiller, senior counselor to the commissioner, and Amy Abernathy, principal deputy commissioner.
  • He believes that the most efficient way for a regulatory pathway for CBD would be through legislation, which would probably focus on CBD only. He said FDA is getting started “now” on this and has been briefing staff on Capitol Hill around its thinking.
  • He expected that the agency will make recommendations on potential legislation this summer.
Gottlieb also noted that he didn’t believe that the Drug Enforcement Agency (DEA) had yet officially rescheduled hemp, which would need to be done. He also raised a separate question of how to distinguish CBD sourced from non-psychoactive hemp from CBD sourced from marijuana containing tetrahydrocannabinol (THC).

With warm regards,
Trish

Comments are closed.
 © 2021 United Natural Products Alliance. All Rights Reserved.
Headquarters: 716 Fourth Avenue Salt Lake City, UT 84103
Mailing Address: 
6503 S Datura Street Littleton, CO 80120
801.474.2572 | info@unpa.com | homepage